A Note on the Potential Clinical Use of Sofosbuvir to Treat COVID-19: the Importance of Protease Inhibitors

SSRN Electronic Journal（2020）

引用 0|浏览8

暂无评分

摘要

In this manuscript we argue that the use of Sofosbuvir as a possible medication in the clinical treatment of COVID-19 can be complemented with HCV protease inhibitors given the homology between the HCV NS3/4A protease and the SARS-CoV-2 Mpro protease.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要